Ironwood Pharmaceuticals director Andrew Dreyfus to resign effective November 1
NegativeFinancial Markets

Andrew Dreyfus, a director at Ironwood Pharmaceuticals, has announced his resignation effective November 1. This change in leadership comes at a crucial time for the company, which is navigating the complexities of the pharmaceutical industry. Dreyfus's departure may raise concerns among investors and stakeholders about the company's direction and stability, making it a significant event to watch.
— Curated by the World Pulse Now AI Editorial System